Literature DB >> 25870089

Sunitinib: the next advance in small-cell lung cancer?

Natasha B Leighl1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25870089     DOI： 10.1200/JCO.2014.60.1815

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  2 in total

1.  Effects of combined sunitinib and extracranial stereotactic radiotherapy on bone marrow hematopoiesis.

Authors:  Johnny Kao; Jonathan Timmins; Junko Ozao-Choy; Stuart Packer
Journal:  Oncol Lett       Date:  2016-07-13       Impact factor: 2.967

2.  Immunotherapeutic maintenance treatment with toll-like receptor 9 agonist lefitolimod in patients with extensive-stage small-cell lung cancer: results from the exploratory, controlled, randomized, international phase II IMPULSE study.

Authors:  M Thomas; S Ponce-Aix; A Navarro; J Riera-Knorrenschild; M Schmidt; E Wiegert; K Kapp; B Wittig; C Mauri; M Dómine Gómez; J Kollmeier; P Sadjadian; K-P Fröhling; R M Huber; M Wolf
Journal:  Ann Oncol       Date:  2018-10-01       Impact factor: 32.976
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.